Product pipeline

TISSUE THERAPEUTIC ASSETS

We are creating next-generation tissue therapies to tackle some of the world’s toughest medical challenges

CLX-100 

Fully vascularized hepatic tissue for treatment of acute liver failure

CLX-200

Fully vascularized islet tissue for treatment of Type I Diabetes

CLX-300

Fully vascularized cardiac tissue for treatment of post-myocardial infarction

PIPELINE
PRODUCT
APPLICATION
INDICATION
PRODUCT DEV. STAGE
LEAD PROGRAM
Liver Tissue
PRODUCT

CLX-100

APPLICATION

Bridge to transplant or recovery

INDICATION

End-stage liver failure

PRODUCT DEVELOPMENT STAGE

Pre-Clinical Development

PRODUCT

CLX-110

APPLICATION

Bridge to transplant or recovery

INDICATION

Late-stage liver disease

PRODUCT DEVELOPMENT STAGE

Discovery

Islet Tissue
PRODUCT

CLX-200

APPLICATION

Responsive insulin replacement

INDICATION

Type 1 Diabetes with hypoglycemia unawareness

PRODUCT DEVELOPMENT STAGE

Discovery

Cardiac Tissue
PRODUCT

CLX-300

APPLICATION

Tissue regeneration

INDICATION

Recovery post-myocardial infraction

PRODUCT DEVELOPMENT STAGE

Discovery

DO WE HAVE SYnERGIES?

We are seeking innovative partners to fast-track the development of our tissue therapies.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.